User Fees

FDA Faces Uncertainty with Sequester, Continuing Resolution

FDA Faces Uncertainty with Sequester, Continuing Resolution

By Zachary Brennan

The US FDA’s ability to inspect facilities, trial sites, and deal with all but its most pressing priorities will be restricted by mandatory government spending cuts according to the Alliance for a Stronger FDA.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers